Phase II study of GEN-001 in combination with avelumab in patients with PD-L1–positive locally advanced, or metastatic gastric cancer (GC) or gastroesophageal junction cancer (GEJC) who have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback